Macrolides in chronic rhinosinusitis a double-blind, randomized, placebo-controlled, multinational, multicenter-trial on prolonged macrolide treatment in patients with moderate/ severe chronic rhinosinusitis.

Trial Profile

Macrolides in chronic rhinosinusitis a double-blind, randomized, placebo-controlled, multinational, multicenter-trial on prolonged macrolide treatment in patients with moderate/ severe chronic rhinosinusitis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Sep 2011

At a glance

  • Drugs Azithromycin (Primary)
  • Indications Bacterial infections; Rhinosinusitis
  • Focus Therapeutic Use
  • Acronyms MACS
  • Most Recent Events

    • 21 Sep 2011 New trial record
    • 26 Jul 2011 Primary endpoint (Sino Nasal Outcome Test) not met according to 12 week results reported in the Allergy.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top